Showing results (61-70 of 137) with videos related to
Sort By:
Pageof 14
Hinyokika Kiyo. Acta Urologica Japonica|May 12, 2006
[A case report: Bilharzial schistosomiasis in the urinary bladder presented with gross hematuria]Toshiki Tsuboi, Kazumasa Matsumoto, Akira Irie, et al.Pathology International|January 6, 2009
L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancerTakeshi Sakata, Golam Ferdous, Tomoko Tsuruta, et al.Japanese Journal of Clinical Oncology|October 17, 2014
A phase 2 trial of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer and without prior chemotherapy (JPN-201 study)Nobuaki Matsubara, Hirotsugu Uemura, Takefumi Satoh, et al.The Journal of Urology|November 16, 2007
Sexual function reported by Japanese and American menShunichi Namiki, Lorna Kwan, Marjorie Kagawa-Singer, et al.Journal of Radiation Research|October 10, 2013
125Iodine monotherapy for Japanese men with low- and intermediate-risk prostate cancer: outcomes after 5 years of follow-upAkane Sekiguchi, Hiromichi Ishiyama, Takefumi Satoh, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 11, 2006
[Cranial nerve palsies due to skull base metastases in patients with prostate cancer: a report of two cases]Masaki Kimura, Takefumi Satoh, Tetsuo Fujita, et al.Urology|September 13, 2011
Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsySatoru Minamida, Takefumi Satoh, Kenichi Tabata, et al.Japanese Journal of Clinical Oncology|November 27, 2014
A phase 2 study of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer who had received docetaxel-based chemotherapyTakefumi Satoh, Hiroji Uemura, Kazunari Tanabe, et al.Analytical and Bioanalytical Chemistry|May 10, 2011
14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluidSatoru Minamida, Masatsugu Iwamura, Yoshio Kodera, et al.International Journal of Radiation Oncology, Biology, Physics|February 27, 2009
Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicityHiromichi Ishiyama, Masashi Kitano, Takefumi Satoh, et al.Pageof 14